minimal residual disease (mrd) monitoring for multiple myeloma is here to stay
Published 7 years ago • 123 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
2:23
the use of immunophenotyping to assess minimal residual disease (mrd) in multiple myeloma
-
2:05
using mrd negativity to measure depth of response & to discontinue treatment in multiple myeloma
-
1:55
mrd monitoring for myeloma
-
2:57
when is the optimal time to measure minimal residual disease (mrd) in myeloma patients?
-
4:05
are we ready to use minimal residual disease (mrd) to direct multiple myeloma therapy?
-
3:19
what impact have new minimal residual disease (mrd) assessment techniques had in myeloma?
-
11:23
challenges and future perspectives for minimal residual disease (mrd) in multiple myeloma
-
2:51
profiling deep minimal residual disease in multiple myeloma
-
2:17
the benefit of detecting minimal residual disease in mm
-
9:25
mgus diagnosis: a step-by-step approach
-
7:07
multiple myeloma coverage on vjhemonc!
-
3:22
the main prognostic factors and why minimal residual disease is becoming crucial in multiple myeloma
-
4:44
minimal residual disease (mrd) | high impact topic (hit)
-
3:40
what’s new in minimal residual disease (mrd) detection in myeloma?
-
3:36
minimal residue disease (mrd) in multiple myeloma
-
3:15
the evolution of mrd for myeloma
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
0:52
mrd for multiple myeloma: is it ready for prime-time?
-
19:41
multiple myeloma: minimal residual disease
-
1:59
methods used to assess mrd status in multiple myeloma
-
2:27
mrd-guided therapy in multiple myeloma
-
5:18
response monitoring in multiple myeloma